期刊文献+

奥美拉唑治疗肝源性溃疡的疗效分析 被引量:1

Effectoflosecin the treatment of hepatogenous ulcer
原文传递
导出
摘要  目的 评价奥美拉唑( 洛赛克) 对肝源性溃疡(HU) 的疗效。方法 对251 例肝硬化经胃镜检查出溃疡的48 例患者,予每日晨服奥美拉唑20mg,疗程4 ~6 周,着重观察胃镜下溃疡愈合情况,并与同期消化性溃疡(PU) 疗效对比分析。结果 4 周愈合率HU 组中,十二指肠溃疡(DU) 为69 .2%(18/26 例),胃溃疡(GU) 为52.9% (9/17 例) ;PU 组中DU 与GU 均为100% (31/31 与6/6 例),两组比较差异有非常显著性(P< 0.01)。6 周愈合率HU 中DU 为84 .6% (22/26),GU 为82 .3(14/17 例) 。肝功能Child C级者溃疡愈合率明显降低。结论 奥美拉唑治疗HU 疗效满意。但疗程较PU 长。HU 的愈合于C级患者较低。 Objective To evaluate the effect oflosecin thetreatment of hepatogenous ulcer (HU) . Methods Forty eightpatients of HUreceived losec 20mg once a day for 4 - 6 weeks.The healing rates of HUwas observed by endoscopyin comparation with peptic ulcer (PU). Results In patients of HU,the overallhealing ratesfor DUat4 weeks was69 .2 % (18/26),theratesfor GUat4 weeks52.9 % (9/17) .In patientsof PU,theoverallhealing ratesfor DUand GUwas100% (31/31 ,6/6),with significantdiffcrence (P< 0.01) compraredto PUgroup.In patients of HU,theoverallhealingratesfor DUand GUat6 weeks was84.6% (22/26),82.3 %(14/17) ,respectively.Conclusion Ourdatashowedtheeffectoflosecintreat mentof HU wassatisfactory,butthe course oftreatment waslonger compare to patients of PU. However, the healing ratesin patients with Child Cgroup wasrelativelylow .
出处 《中华消化杂志》 CAS CSCD 北大核心 1999年第S1期32-33,共2页 Chinese Journal of Digestion
关键词 奥美拉唑 肝源性溃疡 愈合率 Losec Hepatogenous ulcer Healing rate
  • 相关文献

同被引文献11

  • 1寇学斌.门脉高压性膏粘膜病变及消化性溃疡[J].新消化病学杂志,1996,4(3):172-172. 被引量:8
  • 2Geus WP, Mathot RA, Mulder PC et al. Phamacodynamics and kinetics of omeprazole MUPS 20mg and pantoprazole 40mg during repeated oral administration in Helicobacter pyroli- negative subjects [J]. Aliment Pharmacol Ther, 2000,14(8) :1057 - 1064.
  • 3Beil W, Star U, Sewing KF. Pantoprazole : a novel H +/K + AT- Pase inhibitor with an improved pH stability [J]. Eur Pharmacol, 1992,218:265.
  • 4Kataer SS, Shifrin DS, Golovanova OIU,et al. Hepatogenous ulcer: various aspects of its pathogenesis[J].Klin Med Mosk, 1989,67:32 - 36.
  • 5小林迪夫.食道静脉瘤急性大出血の非手术疗法[J].临床成人病,1975,5:1257.
  • 6Mela GS, Savarino V, Vigneri S. Optimizing the information alrtained from continous 24 - hour gastric pH monitoring[J].Am Gastroenterol, 1992,87:961.
  • 7Metavish D,Buckley M, Heel RC. Omeprazole: An update review of its pharmacology and therapeutic use in acid - related disorders [J]. Drugs, 1991,42:138.
  • 8Zech K, Steinijans VW, Huber R, et al. Pharmacokiiinetics and drug interactions retevant ractors factors for the choice of a drug[J]. Int Clin. Pharmacol,1996,34(1):3.
  • 9Huber R, Hartmaun M, Bliesath H, et al. Pharmacokinetics of pantoprazole in man[J]. Clin Pharmacol Ther, 1996,34( Suppl 1 ) :7 - 16.
  • 10陈寿坡.质子泵抑制剂对肠道疾病疗效的评价..全国消化系统用药临床评价学术研讨会论文集[M].北京:中华医学会临床药物评价专家委员会,1997.30.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部